$VREOF

Vireo Growth Inc.

0
1
0

No SEC Form 4 filings for $VREOF in the last 30 days.

Med

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 tm2621363d5_10-1.htm EXHIBIT 10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT by and among VIREO GROWTH INC., SB OHIO HOLDINGS INC., CHICAGO ATLANTIC CREDIT OPPORTUNITIES, LLC, and FARMACEUTICALRX LLC, Dated as of July 30, 2026 Table of Contents Page(s) ARTICLE I. DEFINI

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 tm2621363d3_ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among VIREO GROWTH INC., SUPERNOVA MERGER SUB INC. and PLANET 13 HOLDINGS INC. Dated as of July 26, 2026 TABLE OF CONTENTS Page Article I THE MERGER 3 Section 1.1 The Merg

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 tm2621146d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version Confidential PURCHASE AGREEMENT by and among VIREO HEALTH OF ARCADIA, LLC, COLUMBIA CARE LLC, THE CANNABIST COMPANY HOLDINGS INC., THE TRANSFERRED ENTITIES SET FORTH ON SCHEDULE A and THE SELLER ENTITIES

VREOF sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning VREOF (Vireo Growth Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent VREOF coverage spans corporate actions and financial news.

What's driving VREOF

  • The filing signals a pending change in ownership and capital structure via a securities purchase agreement and convertible notes conversion, which can affect valuation, dilution risk, and financing expectations.

    SEC EDGAR 8-K · Aug 5, 2026

  • The filing signals a pending M&A transaction that can re-rate deal probability, timing, and shareholder value for VREOF.

    SEC EDGAR 8-K · Jul 30, 2026

  • The filing signals a material transaction agreement, but the excerpt provides no deal economics or closing terms yet.

    SEC EDGAR 8-K · Jul 23, 2026

  • Acquisition-driven growth and a sharp revenue jump are presented as the core bull case, implying higher integration and execution risk.

    yahoo.com · Jul 10, 2026

  • The filing signals a pending corporate transaction that can drive deal-spread volatility, liquidity shifts, and event-risk around approvals and closing.

    SEC EDGAR 8-K · Jun 18, 2026

alphai scores every news story that mentions VREOF with an AI model for sentiment and relevance, and aggregates insider trades from Vireo Growth Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $VREOF

Score

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 tm2621363d5_10-1.htm EXHIBIT 10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT by and among VIREO GROWTH INC., SB OHIO HOLDINGS INC., CHICAGO ATLANTIC CREDIT OPPORTUNITIES, LLC, and FARMACEUTICALRX LLC, Dated as of July 30, 2026 Table of Contents Page(s) ARTICLE I. DEFINI

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 tm2621363d3_ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among VIREO GROWTH INC., SUPERNOVA MERGER SUB INC. and PLANET 13 HOLDINGS INC. Dated as of July 26, 2026 TABLE OF CONTENTS Page Article I THE MERGER 3 Section 1.1 The Merg

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 tm2621146d1_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 Execution Version Confidential PURCHASE AGREEMENT by and among VIREO HEALTH OF ARCADIA, LLC, COLUMBIA CARE LLC, THE CANNABIST COMPANY HOLDINGS INC., THE TRANSFERRED ENTITIES SET FORTH ON SCHEDULE A and THE SELLER ENTITIES

$TRLVLow

Better Cannabis Growth Stock: Trulieve or Vireo Growth

Motley Fool compares Trulieve Cannabis (NYSE: TRLV) and Vireo Growth (OTC: VREOF). Trulieve deconsolidated adult-use dispensaries into Harvest to qualify for NYSE listing, reporting Q1 revenue of $287M (-4% YoY) and EPS $0.02. Vireo reported Q1 revenue $106.2M (+333.5% YoY) and EPS loss $0.02, after acquisitions including Schwazze, Eaze, and Hawthorne.

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 tm2617497d3_ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIA

Vireo Growth Inc. (VREOF): Entry into a Material Definitive Agreement

Vireo Growth Inc. (VREOF) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 tm2617497d2_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION (MARKED BY BRACKETS AS “[***]”) HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDE

Related tickers